158 related articles for article (PubMed ID: 9747102)
1. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].
Szucs TD; Smala A; Berger K; Windorfer A
Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102
[TBL] [Abstract][Full Text] [Related]
2. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
Zurn P; Danthine JP
Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of hepatitis A and B vaccination programme in Germany.
Szucs T
Vaccine; 2000 Feb; 18 Suppl 1():S86-9. PubMed ID: 10683559
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
Harris A; Yong K; Kermode M
Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989
[TBL] [Abstract][Full Text] [Related]
6. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.
Boccalini S; Taddei C; Ceccherini V; Bechini A; Levi M; Bartolozzi D; Bonanni P
Hum Vaccin Immunother; 2013 May; 9(5):1119-28. PubMed ID: 23376840
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.
Holliday SM; Faulds D
Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
[TBL] [Abstract][Full Text] [Related]
10. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
11. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
[TBL] [Abstract][Full Text] [Related]
12. [Introduction of general hepatitis B vaccination in Switzerland].
Zimmermann H; Vaudaux B; Kammerlander R
Soz Praventivmed; 1998; 43 Suppl 1():S65-8, S138-42. PubMed ID: 9833270
[TBL] [Abstract][Full Text] [Related]
13. [Child and adolescent hepatitis B vaccination--responsibilities of the public health service].
Nassauer KA
Gesundheitswesen; 1996 Nov; 58(11):616-7. PubMed ID: 9081503
[TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
15. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
16. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
Mangen MJ; Stibbe H; Urbanus A; Siedenburg EC; Waldhober Q; de Wit GA; van Steenbergen JE;
Vaccine; 2017 May; 35(24):3215-3221. PubMed ID: 28483198
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
18. What is the best hepatitis B vaccination strategy for South Africa?
Karim SS
S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
[No Abstract] [Full Text] [Related]
19. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
20. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
Sun PP; Zhang SX; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
